Talazoparib, sold under the brand name Talzenna, is an anti-cancer medication used for the treatment of breast cancer and prostate cancer. [6] It is an orally available poly ADP ribose polymerase PARP inhibitor marketed by Pfizer for the treatment of advanced breast cancer with germline BRCA mutations . [ 9 ]

Oct 17, 2023 · What is talazoparib? Talazoparib is used in adults to treat certain type of breast cancer that has spread to other parts of the body. Talazoparib is also used in adults in combination with other drugs to treat prostate cancer that has spread to other parts of the body and when surgery or other treatments to decrease testosterone levels have not ...

TALZENNA ® treats g BRCA -mutated, HER2- breast cancer that is locally advanced or metastatic. TALZENNA is a proven alternative to chemotherapy in a convenient once-daily oral dose. LEARN ABOUT TALZENNA. gBRCA=germline (or inherited) BRCA, HER2-=human epidermal growth factor receptor 2 (HER2)-negative. TALZENNA is a prescription medicine used:

Oct 21, 2024 · Talzenna (talazoparib) is commonly used to treat certain breast and prostate cancers. Talzenna may also be used for other conditions as determined by your healthcare provider.

Talazoparib is used alone to treat certain types of breast cancer that has spread within the breast or to other areas of the body. Talazoparib is also used with enzalutamide (Xtandi) to treat certain types of prostate cancer that has spread to other parts of the body in men and who have not been helped by certain medical and surgical treatments ...

Talazoparib (Talzenna) is a targeted therapy for treating breast cancer. Find out when it's used, how it works and possible side effects.

Talazoparib is used to treat HER2-negative locally advanced or metastatic breast cancer (cancer that has spread) with a deleterious or suspected deleterious BRCA mutation gene. Your doctor will use a test to check for this mutation before you receive the medicine.

Oct 24, 2023 · Talzenna (talazoparib) is a poly (ADP-ribose) polymerase (PARP) inhibitor that blocks PARP, a protein that is involved with cancer cell growth, regulation and repair. PARP inhibitors stop the cancer cells from being repaired which leads to cell death and a …

Talazoparib is a type of targeted cancer drug. You pronounce it as tal-ah-zo-pa-rib. It is also known as Talzenna. This treatment is for people with HER2 negative breast cancer who have an abnormal change (mutation) in the BRCA1 or BRCA2 genes. You might have talazoparib if you have: secondary breast cancer .

PARPs are proteins that help damaged cells to repair themselves. Talazoparib blocks (inhibits) how PARP proteins work. Without PARP proteins, cancer cells may become too damaged to survive, and then die. This can help control the cancer. Talazoparib is used to treat breast cancer.